# FDA Inspection 1253273 - Pierre Fabre Pharmaceuticals, Inc. - November 01, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/pierre-fabre-pharmaceuticals-inc/01cb2931-62ce-4bde-84b6-ab813b5e54a6
Source feed: FDA_Inspections

> FDA Inspection 1253273 for Pierre Fabre Pharmaceuticals, Inc. on November 01, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1253273
- Company Name: Pierre Fabre Pharmaceuticals, Inc.
- Inspection Date: 2024-11-01
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Postmarketing Surveillance and Epidemiology: Human Drugs
- Product Type: Human Drugs
- Office Name: New Jersey District Office

## Related Documents

- [FDA Inspection 1253273 - 2024-11-01](https://www.globalkeysolutions.net/records/fda_inspections/pierre-fabre-pharmaceuticals-inc/daf73fbf-3f30-450e-a935-f8cfc20e251f)
- [FDA Inspection 1175515 - 2022-07-27](https://www.globalkeysolutions.net/records/fda_inspections/pierre-fabre-pharmaceuticals-inc/5e316c74-1c4a-4b0e-8a3f-5c9b20cfd3fd)
- [FDA Inspection 956345 - 2015-12-30](https://www.globalkeysolutions.net/records/fda_inspections/pierre-fabre-pharmaceuticals-inc/140fdda4-ba34-4f68-82d6-163a0645a609)

Company: https://www.globalkeysolutions.net/companies/pierre-fabre-pharmaceuticals-inc/ee0282e8-44f7-43c1-b3d5-fdc0c75129dc

Office: https://www.globalkeysolutions.net/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248